2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92551°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Çѱ¹-¿µ±¹ °æÁ¦Çù·Â º»°Ý ÃßÁø (2015-03-17)
±¹Á¦ÀÎÀç°³¹ß¼¾ÅÍ, »ê¾÷Çõ¸í4.0 Á᫐ µ¶ÀÏ °¡´Ù (2015-03-17)
Áß¼Ò±â¾÷ ±â¼ú¾Ö·Î ½´ÆÛÄÄÀ¸·Î ÇØ°á (2013-05-27)
½Å¿¹ À̼­¾È, KBS µå¶ó¸¶ ¡®Àú½ºÆ¼½º¡¯ ij½ºÆÃ (2019-07-03)
´ë¿ø¹Ìµð¾î, °¡Á·¹ÂÁöÄà ¡®ÇÁ·»Áꡯ ¾ÞÄÝ °ø¿¬ (2019-02-17)
Ãæ³²µµ, Àå¾ÖÀεî·ÏÁõ ȸ¼öÀ² ¡®65.5%¡¯ (2014-02-02)
¸¸³ª¸ô, ͏®Æ÷´Ï¾Æ ü¸®Çùȸ¿Í ü¸® 1+1 À̺¥Æ® (2018-05-21)
ÀӱݱٷÎÀÚ 10¸í Áß 7¸í, ¡®¼¼±ÝÁ¦µµ¡¯ Àß ¸ð¸¥´Ù (2019-10-26)
Àå¾ÖÀÎÀü¿ëÁÖÂ÷±¸¿ª À§¹Ý ½Ã °úÅ·á 10¸¸¿ø (2012-11-30)
Çö´ëÂ÷, Á¦ÁÖ¿¡¼­ 'Àü±âÂ÷ üÇè À̺¥Æ®' (2021-07-25)
³×ÆÄ ŰÁî, ¾î¸°À̳¯ ¸ÂÀÌ À̺¥Æ® Âü°¡ÀÚ ¸ðÁý (2019-04-10)
'¾È³ç! ÇÔ²²ÇÒ°Ô¡¯ Ä·ÆäÀÎ (2020-10-05)
±Û·Î¹ú»çÀ̹ö´ë, K-ÄÜÅÙÃ÷ Àü¹®Àη ¾ç¼º (2021-11-17)
SKÅÚ·¹ÄÞ 5G MEC ±â¼ú, ºÏ¹Ì ÁøÃâ (2022-12-30)
Çö´ëÀÚµ¿Â÷, Æ÷ÅÍII ÀÏ·ºÆ®¸¯ 1È£Â÷ Àü´Þ (2019-12-17)
LSÀü¼±, Àü±âÂ÷ ºÎǰ ÀÚȸ»ç »óÀå ÃßÁø (2019-12-17)
Çö´ë¿¤¸®º£ÀÌÅÍ, ¡®µð ¿¤ À̸ð¼Ç¡¯ ·¹µå´å ¾î¿öµå (2021-10-27)
CJǪµåºô ¶Ñ·¹Á긣, Èæ´ç ²Ü µµ³Ó µî ½ÅÁ¦Ç° 3Á¾ Ãâ½Ã (2019-07-13)
'¼±»ý´Ô°ú ½Ç½Ã°£ ¼ÒÅëÇÏ´Â È­»óƯ°­' ¹«·á°³¼³ (2020-04-10)
»ï¼ºSDS, ¹Ì±¹ GPU °¡»óÈ­ ±â¾÷¿¡ ÅõÀÚ (2018-05-10)
¸íǰ Á¶¿¬ ÃÖÁ¾³², ¹Âºñ¿¡¼­ ³ë¼÷ÀÚ ¿­¿¬ (2014-06-17)
LGÀüÀÚ ½Ã±×´Ïó Űģ ½ºÀ§Æ®, À¯·´ Ãâ»çÇ¥ (2018-04-19)
¸¶¼¼¶óƼ, »ï¼ºÀüÀÚ ¼ÎÇÁÄ÷º¼Ç°ú °øµ¿ À̺¥Æ® (2020-08-03)
The New England Journal of Medicine and NEJM Group partner w... (2022-11-18)
´ëÇлý 2¸í Áß 1¸í, ¡°¿©¸§¹æÇÐÀº °øºÎÇÏ´Â ±â°£¡± (2014-08-29)
       [ÀÌÀü][1]....[3194][3195][3196][3197][3198][3199][3200][3201][3202]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..